“a nonsignificant trend”

Participants in the LPD group displayed similar profiles to those observed in the CKD mice model, including significant reductions in BW (~−1.4 kg) and BMI (~−0.5 kg/m 2 ; Table 2 ) with a nonsignificant trend toward lower caloric intake despite nutritional support (20.7 ± 1.5 vs 23.8 ± 1.4 kcal/kg/d; p = 0.14).( Figure 2c ) At T0, glucose homeostasis was similar between groups; however, LPD feeding improved glucose tolerance without modification of insulin sensitivity (HOMA-IR) or β -cell function (HOMA- β ), as compared to the ND group ( Figure 2d–e , Table 2 ).

The E′ value (m/s) in the lateral wall demonstrated a statistically significant increase on probenecid in comparison to placebo ( P =0.01), while the septal wall showed a nonsignificant trend ( P =0.14).

However, the participants in the neurological field were more likely to report competence (OR = 1.90; 95% CI: 1.15-3.14; p = 0.040), while those working in geriatrics showed a nonsignificant trend toward higher odds of competence (OR = 1.66; 95% CI: 1.00-2.76; p = 0.140).

The only comparison that survived multiple comparison correction (BH critical value = 0.03) was a significant interaction between gender and CS–IFG phase locking in the beta band (β = 417.99, SE = 189.28, t (55 = 2.21, p = .03, LLCI = 38.65, ULCI = 797.33); simple slope analyses indicated that women tended to perform worse as their CS–IFG phase locking increased in response to STEMIs (β = −6.89, SE = 4.08, t (55) = −1.69, p = .097, LLCI = −401.06, ULCI = 34.18), whereas men showed a nonsignificant trend in the opposite direction (β = 8.81, SE = 5.82, t (55) = 1.51, p = .14, LLCI = −76.15, ULCI = 545.26).

Inflammation remained higher in the RPNI group, showing a nonsignificant trend ( p = 0.14).

Conversely, obtaining antibiotics from official sources showed a nonsignificant trend toward a negative association with strong BI (aOR = 0.16, p = 0.142) [Table 3 ].

There was also a nonsignificant trend for a longer time with an open ADAMTS-13 conformation in group 2 than that in group 1 (0.6 [IQR, 0.4-0.7] vs 0.2 [IQR, 0.1-0.5], respectively; P = .1427).

The area under the curve measurements for these conditions show a nonsignificant trend toward increased migration ( Figure 5 B; p = 0.144).

There was a nonsignificant trend toward a decreased Δ P L at the end of inspiration with decreasing degree of inspiratory synchronization (PC-IMV vs PC-CMV, p = 0.144; PC-IMV vs PC-SIMV, p = 0.152).

There was a nonsignificant trend of higher use of the impaired forelimb in the Galectin-3 KO mice (Fig. 2 a; Mann–Whitney; P = 0.1447).

However, overall accuracy—requiring simultaneous correct identification of both sound type and location—showed only a nonsignificant trend (6.9% gain; t 10 =1.58; P =.145; d =0.48).

In patients with an interruption of treatment due to side effects, a nonsignificant trend for a lower rate of progression was encountered (DCR with interruption 82.4%, without 60.7%, P = 0.146).

There was a nonsignificant trend towards lower rates of normalization of distal esophageal acid exposure (33 vs 76.9%, p = 0.147) and higher rate of device removal (50 vs 14.8%, p = 0.119) in patients with severely DGE.

Propensity‐matched analysis comparing lower‐risk ICU to ward‐admitted patients demonstrated a nonsignificant trend at 100 days (relative risk [ RR ], 0.69; 95% CI , 0.43–1.10; P =0.148).

2 B and D ), although a nonsignificant trend was observed with dHEx ( P = 0.148).

A nonsignificant trend of elevated plasma levels of GDF15 was observed in tumours with increasing intensity ( P =0.148) and fraction ( P =0.326) of GDF15 expression as assessed by immunohistochemistry ( Figures 4A and B ).

A nonsignificant trend toward a longer onset-to-imaging interval was observed in the CT group (median, 431 minutes [IQR, 150–630] versus 265 minutes [IQR, 100–606]; P =0.149).

Antiviral therapy demonstrated a nonsignificant trend toward lower risk of prolonged cough in both influenza (aOR 0.67, 95 % CI: 0.39–1.16, P = 0.15) and COVID-19 (aOR 0.65, 95 % CI: 0.41–1.02, P = 0.06).

Left ventricular ejection fraction Echocardiographic analysis indicated a nonsignificant trend toward improved LVEF in the BAT group and a slight reduction in the control group, with a between‐group difference of 2.5 ± 1.7% ( P < 0.15). 24 The BeAT‐HF study did not report this endpoint 26 and so a meta‐analysis was not possible.

Within the malignant lesion group, patients with a preoperative CA19-9 ≤ 37 U/mL showed a nonsignificant trend toward greater OS compared with those with > 37 U/mL (log‐rank p = 0.15).

Lumateperone, however, showed a nonsignificant trend toward better efficacy (MD = −2.79; 95% CI, −6.60 to 1.01; P = .15) ( Figure 3 ).

The relationship between IgG hypogalactosylation and disease activity was significantly different between strata defined by SE (CRP, p = 0.0003, p Bonferroni = 0.0036) and RF (CRP, p < 0.0001, p Bonferroni < 0.0012), whereas ACPA strata revealed only a nonsignificant trend ( p = 0.15).

Overall survival There was a nonsignificant trend toward improved OS in the tivantinib group (19.8 months; 95% CI, 13.4–27.0) compared with the placebo group (16.9 months; 95% CI, 12.2–20.4; HR, 0.70; P = 0.15) (Fig. 2 b ).

(Indeed, despite this and the relatively small n's, there was a nonsignificant trend towards devaluation (p = 0.15) in this group).

Only a nonsignificant trend for reduced volume was detected for hippocampus (9.06% for Fus + /+ vs. 8.62% for Fus ΔNLS/+ ; p = 0.15; Two-sided Unpaired Student’s t -test) and striatum (9.76% for Fus + /+ vs. 9.89% for Fus ΔNLS/+ ; p = 0.56, Two-sided Unpaired Student’s t -test).